Glucotrack receives ISO 13485:2016 certification for quality management system

Glucotrack, Inc.

Certification awarded by British Standards Institute after Stage I and Stage II assessments.
Covers design and development of Glucotrack's long-term implantable Continuous Blood Glucose Monitor (CBGM).
ISO 13485 is the globally recognized standard for medical device QMS, aligned with FDA QMSR and used in the EU.
CEO Paul Goode calls certification a major step toward delivering high-quality products.
No financial updates or guidance changes provided in the announcement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.